Running title (60 characters): Human gliomas are classified by subtype, grade and cell concentration.
INTRODUCTION
Critical decisions in medicine often depend upon discriminating normal from diseased tissue. For over a century, one of the central methods for identifying pathological processes has been the microscopic review of tissue sections by the trained eye of human pathologists. This paradigm has been simple yet powerful and has allowed for tremendous advances in the understanding, classification and treatment of many human diseases. Over the last few decades newer modalities have been developed to further enhance the capabilities of microscopy-based tissue diagnosis, particularly for the evaluation of tumors.
These tests however remaining largely non-quantitative, require days or even weeks to complete and often assess very specific questions rather than provide comprehensive analytical information. New modalities could further empower the practice of surgical pathology, and assist in defining the extent of a tumor (1), and its relationship to surrounding non-neoplastic tissue (2) (3) (4) (5) . Such new modalities will need to be applicable in real-time, and be validated using standard histopathology evaluation.
Among the most useful ancillary tests in molecular pathology are those that detect changes in nucleic acids that are at the foundation of tumorigenesis: DNA point mutations and chromosomal translocations (6, 7) . Proteomic information is also used regularly in pathology, albeit in a low throughput manner using immunohistochemistry. Mass spectrometry imaging methods have been increasingly applied to cancer research due to its ability of being able to simultaneously map the distribution of large populations of proteins, a feature that is potentially of enormous diagnostic and prognostic value (8) . The lipid constituents of tissues, however, remain entirely unused in diagnostic practice. Extensive investigations have established that the lipid composition of tissues can vary with disease state (9) . A number of studies focus on the molecular changes that occur in cells, signaling the beginning of malignancy and providing a means for early detection and treatment intervention (10, 11) . These lipidomic findings emphasize the importance of determining the composition of lipids in biological tissues for its diagnostic and prognostic value. Despite the diverse lipid composition of various tissues, lipidomic information has until recently been impractical to acquire. Desorption electrospray ionizationmass spectrometry (DESI-MS) and related MS imaging methods have now made acquisition of information on specific lipids and their distribution in tissue highly practical.
DESI-MS is one of a recently developed group of ionization techniques in MS in which samples
are examined in the ambient environment with minimal pretreatment (12, 13) , therefore potentially applicable to real-time analyses. Using DESI, direct lipid analysis from biological samples such as tissue sections can be performed rapidly and routinely (14) . Chemical information obtained can be represented as two-dimensional images recording abundances and spatial distributions of specific ions (15) . In a single analysis, DESI-MS allows the characterization and imaging of many lipids including fatty acyls, glycerophospholipids, glycerolipids and sphingolipids (14) . DESI-MS imaging experiments have been conducted on human cancerous tissues including bladder (16) , kidney (17) , prostate (18) and testicular 4 (19) cancers. In a pilot study using a limited number of specimens, DESI-MS imaging enabled discrimination of different WHO grades of astrocytomas based on lipid profiles (20) .
While imaging of individual ions can be used to distinguish tumor from normal tissue, in most diseases the use of multiple ions enhances diagnostic classification and creates diagnostic categories that often cannot be discerned by examination of single ion data or by the visual examination of broad range mass spectral data. Here, we report on the use of multivariate statistical approaches to provide correlation between lipidomic data acquired by DESI MS imaging and glioma diagnostic information such as subtype, grade, and concentration. A robust classification method was developed, validating the use of lipid profiles for the near real-time characterization of complex gliomas.
MATERIAL AND METHODS

Tissue samples
All tissue samples were cerebrum tumor tissue obtained from the BWH Neurooncology Program Biorepository collection, and analyzed under approved Institutional Review Board (IRB) protocol, with informed written consent obtained by licensed neurosurgeons at BWH. Sample list is shown in Table S1 .
Samples were flash frozen and stored in liquid nitrogen and stored at -80 0 C until sectioned at 14 ȝm thickness using a Microm HM550 cryostat (Mikron Instruments Inc., San Marcos, CA), and thaw mounted onto glass slides. The slides were stored in closed containers at -80° C; prior to analysis they were allowed to come to room temperature, and dried under in a dessicator for approximately 15 minutes.
DESI-MS analysis
The DESI ion source was a lab-built prototype (15) , similar to a commercial source from Prosolia DESI imaging of all tissue samples were run in a randomized way using the same experimental conditions. Samples were obtained in three different sets, and each set included specimens of different subtypes and grades. Each set was run in a random sequence, and under the same experimental conditions. Replicate data were recorded.
Histopathology analysis
H&E stained serial tissue sections were optically scanned using Mirax Micro 4SL telepathology system from Zeiss (Jena, Germany). Regions of heterogeneity within tissue sections were digitally assigned by the pathologist and compared to DESI-MS ion images. Tumor content was evaluated by two neuropathologists (S.S. and K.L.) through examination of an H&E stained tissue section, which was adjacent to the one used for DESI-MS imaging studies. Specimens were evaluated and scored visually with respect to their percentage of tumor nuclei relative to the total nuclei in the sample. Samples were also characterized and assigned a qualitative from normal to infiltrative to solid, corresponding from low to high cellularity.
Statistical Analysis
Samples were divided into training and validation sets for statistical analysis. Each class was defined with similar numbers of specimens, and only specimens with clear diagnosis in accordance with the WHO classification system (22) were used (agreement between two neuropathologists). A software tool was developed to enable the selection of regions of interest (ROI) based on visual inspection of the DESI ion image loaded in Biomap. More specifically, a rectangle with x,y coordinates is drawn over an ion image to create a ROI, and the corresponding spectral data is extracted from the ROI, saved in a separate folder, and converted for further analysis using Three distinct classifiers were built to recognize glioma subtype, grade, and tumor cell concentration. Classification models were built with the Support Vector Machine algorithm. For each classifier, the number of input peaks was automatically detected based on clustering of the peak rankings as determined by the SVM hyperplane separation with an upper limit of 25 peaks to be used by the classifier.
The calculated models were used to classify spectra from selected sub-regions for each validation sample. After classification, the class membership was reported by ClinProTools for every spectrum file with corresponding (x,y) spatial coordinates. To create the overlay image, corresponding H&E-stained optical image, ion image, and class image were imported into an image composition program (23) , and manually aligned using rotation and scaling transforms. For more details, see Supporting Data.
RESULTS
DESI-MS lipid profiles from glioma tissue
DESI-MS imaging was performed on thirty-six human glioma samples including oligodendrogliomas, astrocytomas and oligoastrocytomas of different grades and varying tumor cell concentrations. A complete description of the samples used in this study, including information on glioma subtype, grade, recurrence, tumor cell concentration, EGFR copy number status, 1p/19q status, and p53 immunoreactivity is provided in Table S1 . While analysis was performed in both the positive and negative ion mode, results are described using the data obtained in the negative ion mode, in which the most significant discrimination among lipid profiles was observed. Reproducibility was investigated by analyzing different tissue sections of the same sample on different days under the same experimental conditions ( 
Mass spectrometry imaging
One of the advantages of imaging tissue sections by DESI-MS in comparison to profiling the mass/intensity distributions from tissue extracts is the preservation of morphologic features, providing means for visual differentiation of areas with heterogeneity and infiltration levels within the entire tissue 
section, and for building accurate reference systems. Negative ion mode DESI-MS ion images of sample G23, an oligodendroglioma grade III with 95% tumor cell concentration, are shown in Fig. S5A-H . A relatively homogeneous distribution of detected lipid species was observed in the ion images obtained for this sample, as seen in the ion images of the most abundant ions.
In contrast, sample G33, a glioblastoma with an overall 80% tumor cell concentration, demonstrates marked heterogeneity according to DESI-MS ion images (Fig. 3A-F) . As before, the isomer assignments are not completely unambiguous even though tandem mass spectrometric data has been obtained on ions. Two regions with distinctive lipid profiles were observed from this section (Fig. 3G-H) .
Detailed histopathology evaluation of an H&E stained adjacent tissue section (Fig. 3I) revealed that the region delineated with blue is of grade IV astrocytoma (GBM) with nearly 100% tumor cell concentration and focal vascular proliferation, while the region delineated with red is composed of mainly grey matter infiltrated by glioma cells, with lower tumor cell density (~30%). Indeed, the lipid profile detected in the pure glioblastoma region was consistent with the characteristic lipid profile of other glioblastoma samples, while a distinctly different lipid profile was detected in the region of infiltrated grey matter. 
Statistical Analysis
While qualitative association of lipid profile constitution and spatial distribution with grade and subtype of gliomas can be generally observed from high-density specimens, a more suitable approach is to perform statistical evaluation of the entire data set. The high dimensionality of 2D imaging data together with visual alignment to optical imaging of tissue provides an opportunity to develop robust classification models with the potential to streamline surgical pathology. Classification models were built to recognize glioma subtype and grade based on the WHO tumor classification system (22) . A preliminary model was also built to assess tumor cell concentration in low, medium, and high density subsets based on the overall histopathology evaluation of the specimen. A list of the samples used to build the models is given in Table S2 . All three classifiers had overall recognition capabilities > 99%, and cross validation > 97% (Table 1) . Using the peak calculation criteria reported in the methods section, the software recognized 128 peaks for the subtype dataset, 123 peaks for the grade dataset, and 136 for the concentration dataset as being statistically significant between m/z 200-1000.
Classification models were built from these peak lists with an upper limit of 25 peaks to be used to distinguish classes (Table S3) (Table S4) . concentration (95%), was classified as 96% oligodendroglioma by the subtype classifier and 33% grade II and 67% grade III by the grade classifier. Specimen G41_1 was tested and correctly classified as high tumor cell concentration (100%) by the concentration classifier. Sample G8, astrocytoma grade IV was tested solely in the subtype classifier, which correctly classified it as 98% astrocytoma.
Only ten discrepant results were noted for specimens of the validation set, which is noteworthy due to the heterogeneity and complexity of brain tumors. Note that discrepancy is defined very strictly as meaning not simultaneously satisfying all three criteria. A misassignment of concentration, or grade, or stage is interpreted as discrepant. Five of these were from the tumor cell concentration classifier. This classifier was built considering the overall concentration of the specimens, using limited regions of approximately 100 spectra to define the model. While these ROIs were selected to minimize background signal from the glass, the local tumor cell concentration was not taken into consideration, likewise for the ROIs tested for concentration from the validation set. For the grade classifier, three results from two different cases showed discrepancy with clinical diagnosis. G48 was diagnosed as an astrocytoma grade IV (GBM) with focal gliosarcoma, which is a GBM variant characterized by biphasic tissue pattern with alternating areas displaying glial and mesenchymal differentiation (22) . The classifiers indicated a subtype distribution between the three different subtypes, and 90% of the tested spectra to be of grade II character. The current classifiers have not been trained to recognize this subtype of GBM, which has a high content of connective tissue. Classification of specimen G49 also resulted in a priori discrepancy CAN-11-2465 oligodendrioglioma subtype. The histologic diagnosis of oligoastrocytoma is often challenging in the clinical setting, this glioma type is characterized by poor diagnostic concordance and reproducibility (26, 27) . In an effort to dissect the heterogeneity in the oligoastrocytoma class, IHC was performed to evaluate the status of p53 (26) in addition to considering 1p19q status. The overall results are reported in Table S1, with 7/8 specimens tested to be positive for p53 expression. Fig. 4A-B shows the difference in p53 expression for the negative specimen G12 and for the positive specimen G21 (1p19q evaluation failed), indicating clearly the difference between the two specimens diagnosed as oligoastrocytomas. A strong nuclear staining for p53 often correlates with TP53 mutation and is more typical for low-grade astrocytomas, suggesting an astrocytic character to these tumors. The heterogeneity in this subtype likely explains some of the limitations of the subtype classifier in discriminating oligoastrocytomas from astrocytomas and oligodendriogliomas.
Since spatial information is retained and associated with the spectra throughout the classification process, results can be visualized as a class image using a color code corresponding to each of the classes of a given classifier and aligned to the optical image of an adjacent section. This allows to validate results with expert histopathology evaluation of the tissue, and could become a visualization mean of mass spectrometry based diagnosis. G26 is a very homogenous grade IV astrocytoma (GBM), which is clearly visible from the class imaging results (Fig. 5A) , while G33 heterogeneity is clearly observed with the infiltrative region classified as a different tissue type with oligodendrioglioma character (Fig. 5B) .
The utility of visualizing class images is shown in Fig. 6 for sample G40. This is an focally. DESI mass spectrometry analysis of surgical tissues has the potential to reconcile both by providing detailed diagnostic information in near real time to guide therapy.
Many of the PI, PS and ST species that were qualitatively observed to be different between subtypes of gliomas (Fig. 1A-C) This study validates the preliminary indications of discrimination between astrocytoma types by DESI imaging seen in a preliminary study. It also suggests that the analytical performance characteristics of the methodology are adequate to the challenge of reproducibility and information content to allow classification of tissue into the many sub-types represented by the various combinations of type, grade and concentration encountered in the brain. This ruggedness in performance together with the relative simplicity of the imaging methodology and especially the fact that the tissue is examined without prior chemical treatment makes the approach highly encouraging for development as an intraoperative procedure. We anticipate that the recent development of non-destructive solvent systems for DESI-MS imaging should enable even higher and more accurate correlation between MS lipidomic data and tissue morphology (28) . The molecular information obtained by DESI-MS imaging analysis of glioma tissue can also provide means of understanding the biochemical processes occurring during malignancy. We anticipate that the metabolic variations being captured by DESI-MS imaging may contribute to a reevaluation of the traditional classification systems in medicine. Grey areas correspond to specimens used in a corresponding training set; italicized results are in apparent disagreement with diagnosis and further discussed; boldface type results highlight validation samples not used in any of the training sets.
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